1/3
PROCESS &
FORMULATION
DEVELOPMENT
Kemwell provides extensive mammalian cell culture based products’ development services. The labs have the
capability of performing complete process development, process optimization, scale-up, technology-transfers and
process characterization. Moreover, our scientists have demonstrated the capability to design and execute
development work to meet defined product quality attributes. Kemwell’s integrated cross-functional project teams
comprise of process and analytical development scientists who work closely together leading to excellent product
and process understanding. Each customer project is individually customized to match the customer’s requirements
as per the scope.
Kemwell routinely provides the following development services:
• Upstream and Downstream process Development
• Analytical methods and formulation development (including lyophilized formulations)
• Clone screening and selection
• Cell line stability studies
• Media and cell culture optimization
• Optimizing mfg. processes to improve process time and increase yields/outputs
• Achieving efficient process scale-up
• Reducing of manufacturing costs and time – through process improvements
• Process characterization
• Establishment of scale-down models
• Univariate and multivariate DoE studies
• Studies to define critical and key process parameters, establishment of design space, etc.
• Control strategy
• Head to head comparability studies of biosimilars
• Development stability studies
• Preclinical manufacturing capabilities at 5L, 10L and 80L scale
PROCESS & FORMULATION DEVELOPMENT
UPSTREAM PROCESS DEVELOPMENT
Kemwell’s team of experienced scientists and analysts specialize in mammalian cell culture process development. We
use well versed techniques such as design-of-experiments approach for process optimization to reach optimal titer
values and generate superior quality products. We strive to develop a robust, efficient, scaled up manufacturing
process to deliver consistent product quality.
DOWNSTREAM PROCESS DEVELOPMENT
Kewell’s purification process development team develops robust, economical processes for mammalian cell culture
products. The design-of-experiments approach for process optimization and process characterization is used in order
to achieve optimal yields. Our foremost goal is product quality and we strive to generate superior quality products. A
close collaboration with analytical method development scientists ensures in-process testing scheme development.
Lab infrastructure
• Biosafety cabinets and Laminar Air Flow Units for
aseptic work
• Access controlled cell bank (research cell banks and
working cell banks) storage facility
• CO2 incubators for shake flask experiments
• Bioreactors
• 5L and 10L glass bioreactors
• 80L SS bioreactor
• WAVE bioreactor™
• ATF-2 perfusion
• CEDEX bioanalyzer
• Cell viability analyser
• AKTA purifier™
• AKTA pilot™
• Cogent TFF systems
• Milistak+Pod filtration system
PROCESS & FORMULATION DEVELOPMENT 2/3
CONTACT US
Bangalore, India
+91 80 2698 2400 www.kemwellbiopharma.com
3/3
FORMULATION DEVELOPMENT
Overview
Kemwell offers formulation development services for early and late stage clinical development and commercial
products based on target formulation profiles. Formulation development work is carried out collaboratively with
analytical development groups to ensure that robust and stability indicating analytical methods are used appropriately
during formulation development. Accelerated and real-time stability studies, and varieties of stress stability are
employed to deliver the best formulation for your product.
Preformulation Studies
• Evaluation of biophysical characteristics
• Assessment of ‘thermodynamic stability’
• Identification of critical factors that impact stability
Formulation Screening Studies
• Formulation screening studies to select optimal formulation for the molecule
• Integrated formulation and analytical method development team to ensure right methods are available for
evaluating degradation routes of molecule to enable formulation screening studies
Lyophilization Cycle Development
• Lyophilization cycle development for molecules that may have inherently lower stability in liquid form
• Optimization of each phase of the cycle to ensure an efficient, robust and scalable process
PROCESS & FORMULATION DEVELOPMENT

More Related Content

PDF
Protein Formulation Development
PDF
High-throughput Miniaturized Bioreactors for Cell Culture Process Developmen...
PDF
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...
PDF
Platforms for mAb Commercialization
PDF
Quality by Design at a Biopharma CMO (Contract Manufacturing Organization)
PDF
Mycenax Introduction_
PDF
High-throughput and Automated Process Development for Accelerated Biotherapeu...
PDF
Orphan Biopharmaceuticals & the CDMO
Protein Formulation Development
High-throughput Miniaturized Bioreactors for Cell Culture Process Developmen...
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...
Platforms for mAb Commercialization
Quality by Design at a Biopharma CMO (Contract Manufacturing Organization)
Mycenax Introduction_
High-throughput and Automated Process Development for Accelerated Biotherapeu...
Orphan Biopharmaceuticals & the CDMO

What's hot (20)

PDF
Covering a Spectrum of New Product Development Technologies - From Cells to C...
PDF
Platform Techniques for Preformulation Development for Non-Antibody Products
PDF
Accelerated Stability During Formulation Development of Early Stage Protein T...
PDF
Optimization of Glycosyation & Charge Distribution Through Culture Parameters...
PDF
High Throughput Bioreactor Mimetic in Early and Late Stage Process Development
PDF
From Screening to QC: Development Considerations for Octet Methods
PDF
Getting Biopharmaceutical Production Processes Right the First Time
PDF
High Throughput PEGylation Process Development – Screening & Optimization Stu...
PPT
PDF
Subvisible Particle Characterization: Why Simply Counting Shadows Leaves You ...
PDF
Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...
PDF
Next Generation Recombinant Protein Manufacturing
PDF
A Platform Approach to Preformulation Development for Antibody Products
PDF
Get Proactive With Your Stability Program
PDF
Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...
PDF
Oxidation of a Glycosylated Therapeutic Protein
PDF
Scalability of a Single-Use Bioreactor Platform for Biopharmaceutical Manufac...
PDF
Employing ForteBio Octet platform for the development of a dual-binding poten...
PPTX
General presentation XB
PDF
Integration of Cell Line and Process Development to Expedite Delivery of Bisp...
Covering a Spectrum of New Product Development Technologies - From Cells to C...
Platform Techniques for Preformulation Development for Non-Antibody Products
Accelerated Stability During Formulation Development of Early Stage Protein T...
Optimization of Glycosyation & Charge Distribution Through Culture Parameters...
High Throughput Bioreactor Mimetic in Early and Late Stage Process Development
From Screening to QC: Development Considerations for Octet Methods
Getting Biopharmaceutical Production Processes Right the First Time
High Throughput PEGylation Process Development – Screening & Optimization Stu...
Subvisible Particle Characterization: Why Simply Counting Shadows Leaves You ...
Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...
Next Generation Recombinant Protein Manufacturing
A Platform Approach to Preformulation Development for Antibody Products
Get Proactive With Your Stability Program
Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...
Oxidation of a Glycosylated Therapeutic Protein
Scalability of a Single-Use Bioreactor Platform for Biopharmaceutical Manufac...
Employing ForteBio Octet platform for the development of a dual-binding poten...
General presentation XB
Integration of Cell Line and Process Development to Expedite Delivery of Bisp...
Ad

Similar to Formulation Development Services (20)

DOCX
Esams resume2015-1
PPTX
DCN Company Profile 2015
DOCX
lesliehenson-grochocki
PDF
NANDAKUMAR CV for LinkedIn
PPTX
DCN Diagnostics. Design and Development of Lateral Flow Assay Systems
PDF
Cell line development services
PDF
Biodextris Presentation - New client presentation
PDF
LakePharma service brochure
PDF
Chemical Development \'09
DOC
Samha Joshi 2016 resume
PDF
Biocatalysis services
DOC
Janet Willis CV (2016)
DOC
Praveen galla (2)
PDF
Sartorius Cell Line Development
DOC
Final Resume -Kanagasabapathi
PPTX
Adherent Lentivirus Suspension Production & Manufacturing.pptx
DOC
Charles.Henderson.Res.2016
DOC
AJCormier -new Update 2015 resume
DOCX
KABE LANTRY2 (2)
DOC
Gwendolyn Beagle resume
Esams resume2015-1
DCN Company Profile 2015
lesliehenson-grochocki
NANDAKUMAR CV for LinkedIn
DCN Diagnostics. Design and Development of Lateral Flow Assay Systems
Cell line development services
Biodextris Presentation - New client presentation
LakePharma service brochure
Chemical Development \'09
Samha Joshi 2016 resume
Biocatalysis services
Janet Willis CV (2016)
Praveen galla (2)
Sartorius Cell Line Development
Final Resume -Kanagasabapathi
Adherent Lentivirus Suspension Production & Manufacturing.pptx
Charles.Henderson.Res.2016
AJCormier -new Update 2015 resume
KABE LANTRY2 (2)
Gwendolyn Beagle resume
Ad

Recently uploaded (20)

PDF
Family Law: The Role of Communication in Mediation (www.kiu.ac.ug)
PPTX
interschool scomp.pptxzdkjhdjvdjvdjdhjhieij
PDF
Susan Semmelmann: Enriching the Lives of others through her Talents and Bless...
PPTX
2 - Self & Personality 587689213yiuedhwejbmansbeakjrk
PDF
Kishore Vora - Best CFO in India to watch in 2025.pdf
PDF
ANALYZING THE OPPORTUNITIES OF DIGITAL MARKETING IN BANGLADESH TO PROVIDE AN ...
PDF
Tortilla Mexican Grill 发射点犯得上发射点发生发射点犯得上发生
PPTX
Board-Reporting-Package-by-Umbrex-5-23-23.pptx
PPTX
Project Management_ SMART Projects Class.pptx
DOCX
Center Enamel Powering Innovation and Resilience in the Italian Chemical Indu...
PPTX
Slide gioi thieu VietinBank Quy 2 - 2025
PDF
Solaris Resources Presentation - Corporate August 2025.pdf
DOCX
Hand book of Entrepreneurship 4 Chapters.docx
PPTX
svnfcksanfskjcsnvvjknsnvsdscnsncxasxa saccacxsax
PDF
533158074-Saudi-Arabia-Companies-List-Contact.pdf
PDF
Robin Fischer: A Visionary Leader Making a Difference in Healthcare, One Day ...
DOCX
Center Enamel A Strategic Partner for the Modernization of Georgia's Chemical...
PPT
Lecture notes on Business Research Methods
PDF
#1 Safe and Secure Verified Cash App Accounts for Purchase.pdf
PDF
1911 Gold Corporate Presentation Aug 2025.pdf
Family Law: The Role of Communication in Mediation (www.kiu.ac.ug)
interschool scomp.pptxzdkjhdjvdjvdjdhjhieij
Susan Semmelmann: Enriching the Lives of others through her Talents and Bless...
2 - Self & Personality 587689213yiuedhwejbmansbeakjrk
Kishore Vora - Best CFO in India to watch in 2025.pdf
ANALYZING THE OPPORTUNITIES OF DIGITAL MARKETING IN BANGLADESH TO PROVIDE AN ...
Tortilla Mexican Grill 发射点犯得上发射点发生发射点犯得上发生
Board-Reporting-Package-by-Umbrex-5-23-23.pptx
Project Management_ SMART Projects Class.pptx
Center Enamel Powering Innovation and Resilience in the Italian Chemical Indu...
Slide gioi thieu VietinBank Quy 2 - 2025
Solaris Resources Presentation - Corporate August 2025.pdf
Hand book of Entrepreneurship 4 Chapters.docx
svnfcksanfskjcsnvvjknsnvsdscnsncxasxa saccacxsax
533158074-Saudi-Arabia-Companies-List-Contact.pdf
Robin Fischer: A Visionary Leader Making a Difference in Healthcare, One Day ...
Center Enamel A Strategic Partner for the Modernization of Georgia's Chemical...
Lecture notes on Business Research Methods
#1 Safe and Secure Verified Cash App Accounts for Purchase.pdf
1911 Gold Corporate Presentation Aug 2025.pdf

Formulation Development Services

  • 1. 1/3 PROCESS & FORMULATION DEVELOPMENT Kemwell provides extensive mammalian cell culture based products’ development services. The labs have the capability of performing complete process development, process optimization, scale-up, technology-transfers and process characterization. Moreover, our scientists have demonstrated the capability to design and execute development work to meet defined product quality attributes. Kemwell’s integrated cross-functional project teams comprise of process and analytical development scientists who work closely together leading to excellent product and process understanding. Each customer project is individually customized to match the customer’s requirements as per the scope. Kemwell routinely provides the following development services: • Upstream and Downstream process Development • Analytical methods and formulation development (including lyophilized formulations) • Clone screening and selection • Cell line stability studies • Media and cell culture optimization • Optimizing mfg. processes to improve process time and increase yields/outputs • Achieving efficient process scale-up • Reducing of manufacturing costs and time – through process improvements • Process characterization • Establishment of scale-down models • Univariate and multivariate DoE studies • Studies to define critical and key process parameters, establishment of design space, etc. • Control strategy • Head to head comparability studies of biosimilars • Development stability studies • Preclinical manufacturing capabilities at 5L, 10L and 80L scale PROCESS & FORMULATION DEVELOPMENT
  • 2. UPSTREAM PROCESS DEVELOPMENT Kemwell’s team of experienced scientists and analysts specialize in mammalian cell culture process development. We use well versed techniques such as design-of-experiments approach for process optimization to reach optimal titer values and generate superior quality products. We strive to develop a robust, efficient, scaled up manufacturing process to deliver consistent product quality. DOWNSTREAM PROCESS DEVELOPMENT Kewell’s purification process development team develops robust, economical processes for mammalian cell culture products. The design-of-experiments approach for process optimization and process characterization is used in order to achieve optimal yields. Our foremost goal is product quality and we strive to generate superior quality products. A close collaboration with analytical method development scientists ensures in-process testing scheme development. Lab infrastructure • Biosafety cabinets and Laminar Air Flow Units for aseptic work • Access controlled cell bank (research cell banks and working cell banks) storage facility • CO2 incubators for shake flask experiments • Bioreactors • 5L and 10L glass bioreactors • 80L SS bioreactor • WAVE bioreactor™ • ATF-2 perfusion • CEDEX bioanalyzer • Cell viability analyser • AKTA purifier™ • AKTA pilot™ • Cogent TFF systems • Milistak+Pod filtration system PROCESS & FORMULATION DEVELOPMENT 2/3
  • 3. CONTACT US Bangalore, India +91 80 2698 2400 www.kemwellbiopharma.com 3/3 FORMULATION DEVELOPMENT Overview Kemwell offers formulation development services for early and late stage clinical development and commercial products based on target formulation profiles. Formulation development work is carried out collaboratively with analytical development groups to ensure that robust and stability indicating analytical methods are used appropriately during formulation development. Accelerated and real-time stability studies, and varieties of stress stability are employed to deliver the best formulation for your product. Preformulation Studies • Evaluation of biophysical characteristics • Assessment of ‘thermodynamic stability’ • Identification of critical factors that impact stability Formulation Screening Studies • Formulation screening studies to select optimal formulation for the molecule • Integrated formulation and analytical method development team to ensure right methods are available for evaluating degradation routes of molecule to enable formulation screening studies Lyophilization Cycle Development • Lyophilization cycle development for molecules that may have inherently lower stability in liquid form • Optimization of each phase of the cycle to ensure an efficient, robust and scalable process PROCESS & FORMULATION DEVELOPMENT